Finance

Lists
VVY:AMS
Vivoryon Therapeutics NV
€1.09
-1.80%
(-0.020) 1D
Sep 30, 10:48:45 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VVY...
Open
€1.06
High
€1.10
Low
€1.06
Mkt. cap
32.13M
Avg. vol.
17.75K
Volume
7.28K
52-wk high
€1.84
52-wk low
€1.00
EPS
-€0.22
Shares outstanding
26.07M
No. of employees
13
Open
€1.06
High
€1.10
Low
€1.06
Mkt. cap
32.13M
Avg. vol.
17.75K
Volume
7.28K
52-wk high
€1.84
52-wk low
€1.00
EPS
-€0.22
Shares outstanding
26.07M
No. of employees
13
News stories
From web sources and news partners
About Vivoryon Therapeutics NV
CEO-
Employees13
Founded1997
Headquarters-
SectorBiotechnology
Websitevivoryon.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
806.50K
806.50K
829.50K
829.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02M
1.02M
866.00K
866.00K
Operating expense
1.69M
1.69M
1.70M
1.70M
Total operating expenses
1.69M
1.69M
1.70M
1.70M
Operating income
-1.69M
-1.69M
-1.70M
-1.70M
Other non operating income
-
-
-
-
EBT including unusual items
-1.69M
-1.69M
-1.69M
-1.69M
EBT excluding unusual items
-1.69M
-1.69M
-1.69M
-1.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-132.50K
-132.50K
-
-
Net income
-1.69M
-1.69M
-1.69M
-1.69M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
15.50K
15.50K
13.50K
13.50K
Interest expense
-11.00K
-11.00K
-11.00K
-11.00K
Net interest expenses
4.50K
4.50K
2.50K
2.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.67M
-1.67M
-1.68M
-1.68M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps